Skip to content

EV / sales at other companies

TFX
TeleflexTFX
3.6×-1.0×
Boston Scientific logo
Boston ScientificBSX
-1.5×
Intuitive Surgical logo
Intuitive SurgicalISRG
19.6×-2.4×
Absci Corporation logo
Absci CorporationABSI
246.9×+193×
UFP Technologies logo
UFP TechnologiesUFPT
2.7×-0.5×
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
1.7×+0.3×

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.22B-22.5%
Enterprise value$1.29B
P/S3.8×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Calculated from PROCEPT BioRobotics Corporation’s reported figures.

Based on the most recent quarter.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's EV / sales?
PROCEPT BioRobotics Corporation (PRCT) reported EV / sales of 4.6× in Q1 2026.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.